The effects of pentylenetetrazol, chlordiazepoxide and caffeine in rats tested in the elevated plus-maze depend on the experimental illumination

Behavioural Brain Research

Volumn 217, Issue 1, 2011, Pages 171-177

  Garcia, Andrea Milena Becerra ^a   Cardenas, Fernando P ^b   Morato, Silvio ^c  

^a UNIVERSIDAD DE LA SABANA   (Colombia)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aversion triggering; Caffeine; Chlordiazepoxide; Elevated plus maze; Illumination; Pentylenetetrazol

Indexed keywords

CAFFEINE; CHLORDIAZEPOXIDE; PENTETRAZOLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; DARKNESS; DRUG DOSE COMPARISON; EXPLORATORY BEHAVIOR; ILLUMINATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; CAFFEINE; CHLORDIAZEPOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; LIGHTING; MALE; MAZE LEARNING; PENTYLENETETRAZOLE; RATS; RATS, WISTAR;

EID: 78549244821     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.09.032     Document Type: Article

References (37)

1. Anseloni V.Z., Brandão M.L. Ethopharmacological analysis of behavior of rats using variations of the elevated plus-maze. Behav Pharmacol 1997, 8:533-540.
2. Anseloni V.Z., Motta V., Lima G., Brandão M.L. Behavioral and pharmacological validation of the elevated plus-maze constructed with transparent walls. Braz J Med Biol Res 1995, 28:597-601.
3. Bell-Horner C.L., Dibas M., Huang R.Q., Drewe J.A., Dillon G.H. Influence of subunit configuration on the interaction of picrotoxin-site ligands with recombinant GABA(A) receptors. Brain Res Mol Brain Res 2000, 76(1):47-55.
4. Brockwell N.T., Higgins S.T., Hughes J.R., Bickel W.K. Caffeine induced place and taste conditioning: production of dose dependent preference and aversion. Pharmacol Biochem Behav 1993, 38:513-517.
5. Cardenas F., Lamprea M.R., Morato S. Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze. Behav Brain Res 2001, 122:169-174.
6. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005, 29(8):1193-1205.
7. Chaouloff F., Durand M., Morméde P. Anxiety-and activity-related effects of diazepam and chlordiazepoxide in the rat light/ark and dark/light test. Behav Brain Res 1997, 85:27-35.
8. Cruz A.P.M., Frey F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994, 49:71-176.
9. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task. Behav Brain Res 2008, 188:136-153.
10. Ennaceur A., Michalikova S., van Rensburg R., Chazot P.L. Distinguishing anxiolysis and hyperactivity in an open space behavioral test. Behav Brain Res 2010, 207:84-98.
11. File S.E. Behavioral detection of anxiolytic action. Experimental approaches to anxiety and depression 1992, 25-44. John Willey and Sons, New York. J.M. Elliott, D.J. Heal, C.A. Marsden (Eds.).
12. File S.E., Lister R.G. Do the reductions in social interactions produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions?. Neuropharmacology 1992, 23:793-796.
13. File S.E., Hyde J.R.G. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilizers and stimulants. Pharmacol Biochem Behav 1979, 11:65-69.
14. Garcia A.M.B., Cardenas F.P., Morato S. Effect of different illumination levels on rat behavior in the elevated plus-maze. Physiol Behav 2005, 85:265-270.
15. Garrett B.E., Griffiths R.R. The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol Biochem Behav 1997, 57(3):533-541.
16. Griebel G., Moreau J.L., Jenck F., Martin J.R., Misslin R. Some critical determinants of the behavior of rats in the elevated plus-maze. Behav Proc 1993, 29:37-48.
17. Handley S.L., McBlane J.W. 5-HT drugs in animal models of anxiety. Psychopharmacol 1993, 112:13-20.
18. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behavior. Naunyn Schmiedebergs Arch Pharmacol 1984, 327:1-5.
19. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996, 54:21-30.
20. Huang R., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant-γ-aminobutyric acid type A (GABAa) receptors: mechanism and site de action. J Pharmacol Exp Ther 2001, 298:986-994.
21. Imhof J.T., Coelho Z.M.I., Schmitt M.L., Morato G.S., Carobrez A.P. Influence of gender and age on performance of rats in the elevated plus-maze apparatus. Behav Brain Res 1993, 56:177-180.
22. Johnston A.L., File S.E. Sex differences in animal tests of anxiety. Physiol Behav 1991, 49:245-250.
23. Jung M.E., Lal H., Gatch M.B. The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci Biobehav Rev 2002, 26:429-439.
24. Lister R. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987, 92:180-185.
25. Martinez J.C., Cardenas F.P., Lamprea M.R., Morato S. The role of vision and proprioception in the aversion of rats to the open arms of an elevated plus maze. Behav Proc 2002, 60:15-26.
26. Morato S., Castrechini P. Effects of floor surface and environmental illumination on exploratory activity in the elevated plus-maze. Braz J Med Biol Res 1989, 22:707-710.
27. Nasello A.G., Machado C., Bastos J.F., Felicio L.F. Sudden darkness induces a high activity-low anxiety state in male and female rats. Physiol Behav 1998, 63:451-454.
28. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 86:149-167.
29. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986, 24:525-529.
30. Ramanjaneyulu R., Ticku M.K. Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol 1984, 98:337-345.
31. Ramos A., Pereira E., Martins G.C., Wehrmeister T.D., Izidio G.S. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav Brain Res 2008, 193:277-288.
32. Rodgers R.J., Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. Ethology and psychopharmacology 1994, 9-44. John Willey and Sons, New York. S.J. Cooper, C.A. Hendrie (Eds.).
33. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
34. Silva R.H., Frussa-Filho R. The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. J Neurosci Methods 2000, 102:117-121.
35. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 1993, 44:463-469.
36. Valle F.P. Effects of strain, sex, and illumination on open-field behavior of rats. Am J Psychol 1970, 83:103-111.
37. Wong C.G.T., Bottiglieri T., Snead O.C. GABA, γ-hydroxybutyric acid, and neurological disease. Annu Neurol 2003, 54(Suppl. 6):S3-S12.